Join the Global Brintellix team in this mid-year special episode of the Brintellix News Network update.

See how Brintellix globally is performing in these highly uncertain times.

Learn how Global Strategy is being implemented locally, and hear more about the new Brintellix DVA that is arriving in early October

That and many more things in this short mid-year update from the Global Brintellix team - lets stay Brilliant together!

We recommend you download this episode while connected to WiFi

Did you know, 70–80% of patients during a depressive episode have significant anhedonia, and a sizable percentage also experience it between occurrences. Equipping yourself with the latest research prepares you for influential conversations with Dr. Mood and Dr. Function. In this episode of Brilliant Together, Dr. Roger McIntyre joins Global Senior Medical Advisor, Michael Cronquist Christensen, to share his first-hand experience and research about the unique effect Brintellix has over other antidepressants.

Dr. Roger McIntyre is an expert in depression therapy and a doctor whom Thomson-Reuters named one of the most influential scientific minds in 2014–2019. Dr. McIntyre is a Professor of Psychiatry and Pharmacology at the University of Toronto and the head of the Mood Disorders Psychopharmacology Unit at University Health Network in Toronto.

Key Takeaways:

[1:02] How common is anhedonia in patients with depression?

[2:01] Dr. McIntyre describes what a typical anhedonic patient experiences.

[4:26] Dr. McIntyre shares his first-hand clinical experience with vortioxetine in patients with depression.

[6:49] What are the distinctly different effects vortioxetine has over other antidepressants?

[8:33] Dr. McIntyre defines emotional blunting and addresses the role other antidepressants may have in its origin.

Resources:

Brintellix Podcast

This episode of Brilliant Together includes insights from crucial research on Vortioxetine and its effects on patients with a common symptom of depression, Anhedonia. Dr. Roger McIntyre, Professor of Psychiatry and Pharmacology at the University of Toronto and the head of the Mood Disorders Psychopharmacology Unit at University Health Network in Toronto, details the results of his study on Vortioxetine. How it may improve patient quality of life by reducing the amount of emotional blunting commonly caused by SSRIs and increase the ability to anticipate pleasure.

Key Takeaways:

[:36] Anhedonia is composed of two separate, overlapping constructs that reduce function.

[3:38] Can emotional blunting be reduced?

[6:32] The research behind improving motivation and the sucrose preference test.

[8:30] Dr. McIntyre reveals the results of his study on the effect of vortioxetine on anhedonia.

[12:25] How vortioxetine differs from other antidepressants in studies based on SHAPS.

[19:00] To improve patient quality of life and function, treatment needs to include improved experience and anticipation.

Resources:

Brintellix Podcast

Welcome to the Brilliant Together Podcast series. This episode showcases the major milestones of the Brintellix strategy evolution and the key to unlock successful sales. To reach the full potential of Brintellix, we need to go after the largest opportunities for growth. We do that by understanding the buying process and decision-making drivers of the three doctor types most likely to prescribe Brintellix to patients with depression. If we strategically focus on the patients whose symptoms meet those of Detached Debbie, we offer physicians a positive experience and accelerate the journey for low prescribers to become high prescribers.

Key Takeaways:

[5:35] Meet the three doctor types who treat patients with depression, Dr. Mood, Dr. Function, and Dr. Progressive.

[11:55] What type of patient offers the largest opportunity for growth?

[14:43] Low prescribers will have positive experiences prescribing Brintellix to the Detached Debbie targeted patient segment.

[19:20] How Brintellix increases a patient's chances of remission and works within a physician's engrained treatment habit.

[23:19] Move the buying process forward by reframing the language to reflect progress and initiate Brintellix.

Resources:

Brintellix Podcast

Welcome to our Brintellix podcast. This podcast trailer provides you the highlighted overview and the best bits of our pilot show, teasing what's coming soon to our Brintellix podcast series.

This Brintellix podcast is particularly designed for you to tune into during your spare time. Hosted by the Global Brintellix Marketing Team and cross functional team, it dives into the stories of how strategic choices and elements built the brand strategy that started a successful journey for Brintellix and the MDD patients.

Thank you for tuning into this trailer show. We Brilliant Together